FUNDAMENTALS · Fundamentals · KR Healthcare

Value Added Technology (043150) Fundamentals 2026 — P/E 5.9x, Revenue Analysis | SniperIQ

Value Added Technology (043150) is a KR-listed Healthcare company in Medical - Specialties with a market capitalization of ₩250.0B, trading at ₩16830.00 on the KOE. This SniperIQ fundamentals page covers Value Added Technology's valuation (P/E 5.9x, P/B 0.5x), profitability (net margin 9.8%), revenue (₩426.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap₩250.0B
P/E (TTM)5.9x
Net Margin9.8%
Revenue (FY25)₩426.4B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Value Added Technology's market cap?

Value Added Technology (043150) has a market capitalization of approximately ₩250.0B, trading at ₩16830.00 on the KOE. Market cap moves with the live share price.

What is Value Added Technology's P/E ratio?

Value Added Technology's trailing twelve-month P/E ratio is 5.9x, with a price-to-book (P/B) of 0.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Value Added Technology?

Value Added Technology runs a net profit margin of 9.8%, a gross margin of 50.6%, and an operating margin of 12.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Value Added Technology generate?

Value Added Technology reported revenue of ₩426.4B for fiscal year 2025, with net income of ₩40.1B and earnings per share (EPS) of 2701. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Value Added Technology pay a dividend?

Value Added Technology offers a trailing dividend yield of about 0.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Value Added Technology financially healthy?

Value Added Technology carries a debt-to-equity ratio of 0.09x and a current ratio of 3.07x, with a market beta of 0.77. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Value Added Technology a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Value Added Technology (043150) the key facts are: market cap ₩250.0B, P/E 5.9x, revenue ₩426.4B, 52-week range 16530-27350. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Value Added Technology's full fundamentals live

Get Value Added Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Nakanishi (7716) fundamentals · Nihon Kohden (6849) fundamentals · Nipro (8086) fundamentals · Korea United Pharm (033270) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons